Squarepoint’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $99.9M | Buy |
830,857
+764,712
| +1,156% | +$88.3M | 0.12% | 165 |
|
|
2025
Q4 | $6.96M | Sell |
66,145
-1,068,923
| -94% | -$100M | 0.01% | 1254 |
|
|
2025
Q3 | $95.3M | Sell |
1,135,068
-1,967,514
| -63% | -$162M | 0.1% | 224 |
|
|
2025
Q2 | $246M | Sell |
3,102,582
-773,352
| -20% | -$61.5M | 0.26% | 59 |
|
|
2025
Q1 | $348M | Buy |
3,875,934
+2,036,841
| +111% | +$190M | 0.42% | 27 |
|
|
2024
Q4 | $183M | Buy |
1,839,093
+321,063
| +21% | +$33.1M | 0.18% | 82 |
|
|
2024
Q3 | $172M | Buy |
1,518,030
+648,109
| +75% | +$77M | 0.27% | 49 |
|
|
2024
Q2 | $108M | Buy |
869,921
+430,971
| +98% | +$55.5M | 0.18% | 89 |
|
|
2024
Q1 | $57.9M | Sell |
438,950
-956,761
| -69% | -$118M | 0.1% | 211 |
|
|
2023
Q4 | $152M | Buy |
1,395,711
+462,300
| +50% | +$48M | 0.29% | 47 |
|
|
2023
Q3 | $96.1M | Buy |
933,411
+720,233
| +338% | +$77.6M | 0.24% | 73 |
|
|
2023
Q2 | $24.6M | Buy |
213,178
+194,171
| +1,022% | +$22M | 0.08% | 301 |
|
|
2023
Q1 | $2.02M | Sell |
19,007
-67,479
| -78% | -$7.29M | 0.01% | 1409 |
|
|
2022
Q4 | $9.6M | Sell |
86,486
-25,062
| -22% | -$2.56M | 0.04% | 512 |
|
|
2022
Q3 | $9.61M | Sell |
111,548
-678
| -0.6% | -$60.5K | 0.05% | 445 |
|
|
2022
Q2 | $10.2M | Buy |
112,226
+85,015
| +312% | +$7.54M | 0.06% | 391 |
|
|
2022
Q1 | $2.23M | Sell |
27,211
-198,382
| -88% | -$15.6M | 0.01% | 1089 |
|
|
2021
Q4 | $17.3M | Buy |
225,593
+176,216
| +357% | +$14M | 0.05% | 347 |
|
|
2021
Q3 | $3.71M | Buy |
49,377
+12,697
| +35% | +$966K | 0.01% | 915 |
|
|
2021
Q2 | $2.85M | Buy |
+36,680
| New | +$2.73M | 0.01% | 990 |
|
|
2021
Q1 | – | Sell |
-251,970
| Closed | -$18.6M | – | 3435 |
|
|
2020
Q4 | $19.7M | Buy |
251,970
+65,429
| +35% | +$5M | 0.15% | 120 |
|
|
2020
Q3 | $14.8M | Sell |
186,541
-54,202
| -23% | -$4.25M | 0.2% | 116 |
|
|
2020
Q2 | $17.8M | Buy |
240,743
+50,157
| +26% | +$3.78M | 0.29% | 65 |
|
|
2020
Q1 | $14M | Buy |
+190,586
| New | +$15M | 0.36% | 47 |
|
|
2019
Q4 | – | Sell |
-97,053
| Closed | -$7.97M | – | 2682 |
|
|
2019
Q3 | $7.8M | Buy |
97,053
+10,151
| +12% | +$814K | 0.07% | 348 |
|
|
2019
Q2 | $6.95M | Buy |
+86,902
| New | +$6.65M | 0.07% | 337 |
|
|
2019
Q1 | – | Sell |
-101,791
| Closed | -$7.42M | – | 2332 |
|
|
2018
Q4 | $7.42M | Buy |
101,791
+74,178
| +269% | +$5.24M | 0.09% | 299 |
|
|
2018
Q3 | $1.87M | Sell |
27,613
-151,236
| -85% | -$9.64M | 0.02% | 750 |
|
|
2018
Q2 | $10.4M | Buy |
178,849
+166,281
| +1,323% | +$9.38M | 0.14% | 216 |
|
|
2018
Q1 | $653K | Buy |
+12,568
| New | +$679K | 0.01% | 983 |
|
|
2017
Q4 | – | Sell |
-463,248
| Closed | -$28.3M | – | 2248 |
|
|
2017
Q3 | $28.3M | Buy |
463,248
+73,698
| +19% | +$4.47M | 0.54% | 26 |
|
|
2017
Q2 | $23.8M | Buy |
389,550
+186,370
| +92% | +$11.3M | 0.47% | 28 |
|
|
2017
Q1 | $12.3M | Sell |
203,180
-98,944
| -33% | -$6M | 0.34% | 67 |
|
|
2016
Q4 | $17M | Buy |
+302,124
| New | +$17.7M | 0.69% | 11 |
|
|
2016
Q2 | – | Sell |
-79,106
| Closed | -$3.99M | – | 1261 |
|
|
2016
Q1 | $3.99M | Buy |
79,106
+44,684
| +130% | +$2.19M | 0.31% | 67 |
|
|
2015
Q4 | $1.74M | Buy |
+34,422
| New | +$1.74M | 0.19% | 114 |
|
|
2015
Q1 | – | Sell |
-36,470
| Closed | -$1.98M | – | 472 |
|
|
2014
Q4 | $1.98M | Buy |
+36,470
| New | +$2.03M | 1.91% | 5 |
|
Other funds holding MRK
VCM
VPM
Squarepoint's MRK Position: Q1 2026 in Review
Squarepoint increased its Merck (MRK) stake by 1,156% in Q1 2026, buying an estimated $88.3M and bringing the position to 830,857 shares worth $99.9M. The position accounts for 0.12% of the portfolio, ranked #165.
Squarepoint first reported a position in MRK in Q4 2014 and has held it in 37 quarters since. The position peaked at $348M in Q1 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Squarepoint held 830,857 shares of Merck worth $99.9M as of Q1 2026.
- Squarepoint bought 764,712 Merck shares in Q1 2026, an estimated $88.3M.
- Merck made up 0.12% of Squarepoint's portfolio in Q1 2026, its #165 holding.
- Squarepoint first reported a position in Merck in Q4 2014 and has held it in 37 quarters since.
- Squarepoint's Merck position peaked at $348M in Q1 2025.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.